Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection.
about
Influenza and Bacterial Superinfection: Illuminating the Immunologic Mechanisms of DiseaseThe role of viral, host, and secondary bacterial factors in influenza pathogenesisThe immunology of influenza virus-associated bacterial pneumoniaLinezolid has unique immunomodulatory effects in post-influenza community acquired MRSA pneumoniaLimited Efficacy of Antibacterial Vaccination Against Secondary Serotype 3 Pneumococcal Pneumonia Following Influenza Infection.Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination PostinfluenzaAn agent-based model simulation of influenza interactions at the host level: insight into the influenza-related burden of pneumococcal infections.Applying Convergent Immunity to Innovative Vaccines Targeting Staphylococcus aureus.Extracellular Adenosine Protects against Streptococcus pneumoniae Lung Infection by Regulating Pulmonary Neutrophil RecruitmentResistance to Acute Macrophage Killing Promotes Airway Fitness of Prevalent Community-Acquired Staphylococcus aureus Strains.Increased Mortality Rates Associated with Staphylococcus aureus and Influenza Co-infection, Maryland and Iowa, USA(1).Differential Type I Interferon Signaling Is a Master Regulator of Susceptibility to Postinfluenza Bacterial Superinfection.Host Physiologic Changes Induced by Influenza A Virus Lead to Staphylococcus aureus Biofilm Dispersion and Transition from Asymptomatic Colonization to Invasive DiseaseNox2-derived oxidative stress results in inefficacy of antibiotics against post-influenza S. aureus pneumonia.Exploring NAD+ metabolism in host-pathogen interactions.Immunomodulators targeting MARCO expression improve resistance to postinfluenza bacterial pneumonia.RIG-I Activation Protects and Rescues from Lethal Influenza Virus Infection and Bacterial Superinfection.Novel protective mechanism for interleukin-33 at the mucosal barrier during influenza-associated bacterial superinfection.Low-Dose Oxygen Enhances Macrophage-Derived Bacterial Clearance following Cigarette Smoke Exposure.Positive Contribution of Adjuvanted Influenza Vaccines to the Resolution of Bacterial Superinfections.The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: A key role for mathematical modelling.K63-Linked Polyubiquitination on TRAF6 Regulates LPS-Mediated MAPK Activation, Cytokine Production, and Bacterial Clearance in Toll-Like Receptor 7/8 Primed Murine Macrophages.Interleukin-22 immunotherapy during severe influenza enhances lung tissue integrity and reduces secondary bacterial systemic invasion.Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.A Model of Superinfection of Virus-Infected Zebrafish Larvae: Increased Susceptibility to Bacteria Associated With Neutrophil Death.Coinfection With Influenza A Virus and : An Underrecognized Impact on Host Resistance and Tolerance to Pulmonary Infections
P2860
Q26799132-F9D49C95-26D0-4167-B885-C37A9B7D895BQ28082144-455140D8-5388-420E-BF1C-D9D26437381FQ28084679-2DBD30AB-AF1A-49F7-9D7B-97082CA71B4BQ28543159-B90DCA8E-0A58-4D09-AAD6-5DF3331E70A5Q30204865-B43BF1F1-B00E-452B-B225-38D438DF5BA8Q30370676-93CF73D6-A1BB-4441-85BD-A0A97F39B47CQ30394781-081053E2-8B40-4D03-81B9-A709579DA642Q30402689-F0A6ED12-381B-493D-A849-90569CFA1A42Q34250054-3E79558A-F470-455E-A519-BC8B5706EA4CQ35757502-7A852B18-B888-4B20-8745-2D4629D1CDC7Q36905555-49D03BD2-BD94-447D-9B42-52298FAED33DQ37031499-C06EC731-276D-4FB7-8727-D62DB546A85AQ37123447-91DFB16B-D0AA-4176-8A6F-1B47B0846429Q37168719-7ACC5C3C-52CA-44B8-905B-88F3AB932892Q37197883-B178A0E3-8911-429B-BD13-D81FD13AF31AQ38683395-EA3D0EA5-8963-47F9-84C5-9ABE6A3A7055Q38707767-C1577D3A-E5C5-466A-9A41-8954E1ECE909Q40100763-EFAA50EF-B44A-4DD2-A19E-B9CF2A4C3E04Q40246354-488AB5C4-6714-46E0-8E68-2DD28DBC8E6AQ40617084-7BDA012D-E4F1-40AA-A437-06FE894DAF51Q40779990-08A9CCFE-A79B-4A0F-A0ED-2BEB418A61F1Q47576940-5959D2D8-7201-45E3-A171-BE5D9BC66455Q49979068-C040A384-B80C-406B-BD7B-8469EA1252DEQ52668324-B20117E7-9C6F-4416-8928-D4B3E31F687FQ52691346-ABB7888E-B302-4F5D-BB0A-473C44CA941EQ53516441-99CE5CFB-2C66-4BE6-8B56-0B7BFC76854BQ55035775-B6950C7D-5D7B-4A81-A5E4-2F10033D44FCQ58698988-296E85F7-B4F7-4C76-883C-F70A002A815F
P2860
Influenza infection suppresses NADPH oxidase-dependent phagocytic bacterial clearance and enhances susceptibility to secondary methicillin-resistant Staphylococcus aureus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influenza infection suppresses ...... aphylococcus aureus infection.
@en
Influenza infection suppresses ...... aphylococcus aureus infection.
@nl
type
label
Influenza infection suppresses ...... aphylococcus aureus infection.
@en
Influenza infection suppresses ...... aphylococcus aureus infection.
@nl
prefLabel
Influenza infection suppresses ...... aphylococcus aureus infection.
@en
Influenza infection suppresses ...... aphylococcus aureus infection.
@nl
P2860
P356
P1476
Influenza infection suppresses ...... aphylococcus aureus infection.
@en
P2093
P2860
P304
P356
10.4049/JIMMUNOL.1303049
P407
P577
2014-02-21T00:00:00Z